Clinical Trial Update: Lidocaine Intravenous in the Emergency Department For Sickle Cell Crisis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating intravenous lidocaine for emergency department management of sickle cell crisis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain Acute
• Sickle Cell Crisis
• Sickle Cell Disease

Drugs mentioned

• Lidocaine (intravenous) (lidocaine)

Snippet

Sponsor: Community Medical Center, Toms River, NJ | Conditions: Sickle Cell Disease, Sickle Cell Crisis | Phase 2 | Status: UNKNOWN